Developing and Testing an Online Pathway From Screening to Treatment for Depression in Oncology: iPath*D (Aim 2)

Part of paid clinical trials in Saint Johnsbury, Vermont.

Sponsor
Dartmouth-Hitchcock Medical Center
Study ID
NCT05302375
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • iPath*D — OTHER
    Online pathway from screening to treatment for depression in cancer patients.

Study Details

The purpose of this study is to determine the extent to which an online pathway to depression treatment (iPath\*D) is acceptable and usable to patients receiving cancer treatment who report symptoms of depression.

Key Dates

Start date
Jul 1, 2024
Status verified
Mar 2025
Primary completion
Jun 30, 2025
Completion
Dec 15, 2025

Study Design

Enrollment
30 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER

Arms

  • Experimental: iPath*D
    An online platform that connects patients screening positive for clinically significant depression in cancer settings to a range of online and inperson evidence-based treatments, facilitated by an interactive DA.

Primary Outcome Measure

System usability [ Time Frame: 2 weeks ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Dartmouth Cancer Center St. JohnsburySaint JohnsburyVermont05819
Lora Schofield, RN, OCN, BSN
[email protected]
802-473-4100

Find similar trials in Saint Johnsbury, VT

By condition
Depression
By specialty
PsychiatryMental healthBehavioral health
By research site
Dartmouth Cancer Center St. Johnsbury· Saint Johnsbury, VT

Related Studies